Search alternatives:
larger decrease » marked decrease (Expand Search)
we decrease » nn decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
a larger » a large (Expand Search), _ larger (Expand Search), _ large (Expand Search)
has a » has _ (Expand Search), had a (Expand Search)
larger decrease » marked decrease (Expand Search)
we decrease » nn decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
a larger » a large (Expand Search), _ larger (Expand Search), _ large (Expand Search)
has a » has _ (Expand Search), had a (Expand Search)
-
1
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
Published 2025“…(C) Mutualism also promotes an increase in network connectance when introduced into assembled communities, while stopping mutualistic interactions from entering an assembled system slowly decreases it. (D) As a result, the introduction of mutualistic interactions promotes a growth in complexity in communities where it was once established as low, while stopping the introduction of further mutualistic interactions causes a slight decrease in complexity. …”
-
2
-
3
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
-
4
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
-
5
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
-
6
-
7
Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes
Published 2025Subjects: -
8
Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes
Published 2025Subjects: -
9
-
10
Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX
Published 2024“…Introduction<p>Early life gut microbiomes are important for brain and immune system development in animal models. Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
-
11
Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX
Published 2024“…Introduction<p>Early life gut microbiomes are important for brain and immune system development in animal models. Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”
-
12
Heart failure decreases adipocyte progenitors with impaired differentiation capacity toward mature adipocytes
Published 2025“…Adipose dysfunction might worsen HF as adipose tissue has been found to have cardioprotective effects mediated through its metabolic and endocrine functions, and therefore, could serve as a novel therapy target. …”
-
13
Table_3_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.docx
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
14
Image_4_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
15
Image_1_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
16
Image_3_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
17
Image_8_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
18
Image_2_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
19
Table_1_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.docx
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”
-
20
Image_7_Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity.TIF
Published 2025“…<p>Impaired endometrial receptivity is one of the major causes of recurrent implantation failure (RIF), although the underlying molecular mechanism has not been fully elucidated. In the present study, we demonstrated that chromodomain Y like (CDYL) was highly expressed in the endometrium at mid-secretory phase during the normal menstrual cycles. …”